Silence Therapeutics
SLN
#8758
Rank
S$0.15 B
Marketcap
$3.32
Share price
3.15%
Change (1 day)
-88.52%
Change (1 year)

P/S ratio for Silence Therapeutics (SLN)

P/S ratio as of April 2025 (TTM): 2.41

According to Silence Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.8457. At the end of 2024 the company had a P/S ratio of 34.0.

P/S ratio history for Silence Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202434.0108.28%
202316.3-16.83%
202219.6-29.27%
202127.8